{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:21:09Z","timestamp":1769512869072,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.heliyon.2023.e17477","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T22:35:14Z","timestamp":1687386914000},"page":"e17477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibody level dynamics until after the third dose of COVID-19 vaccination"],"prefix":"10.1016","volume":"9","author":[{"given":"Nanae","family":"Asahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7160-5635","authenticated-orcid":false,"given":"Ippei","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Torii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Iwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2023.e17477_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"China novel coronavirus investigating and research team. Novel coronavirus from patients with pneumonia in China 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e17477_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 vaccine: a comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17477_bib3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","article-title":"Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2","volume":"27","author":"Ebinger","year":"2021","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e17477_bib4","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e17477_bib5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/v13071364","article-title":"Neutralizing antibodies in COVID-19 patients and vaccine recipients after two doses of BNT162b2","volume":"13","author":"Favresse","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17477_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Lindsey","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17477_bib7","doi-asserted-by":"crossref","first-page":"1861.e1","DOI":"10.1016\/j.cmi.2021.07.042","article-title":"Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan","volume":"27","author":"Kageyama","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17477_bib8","article-title":"Age-dependent reduction in neutralization against alpha and beta variants of BNT162b2 SARS-CoV-2","volume":"9","author":"Kawasuji","year":"2021","journal-title":"Vaccine-Induced Immun. Microbiol. Spectr."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17477_bib9","first-page":"1725","article-title":"Impact of age and sex on antibody response following the second dose of COVID-19 BNT162b2 mRNA","volume":"9","author":"Vassilaki","year":"2021","journal-title":"Vaccine Greek Healthc. Work. Microorg."},{"key":"10.1016\/j.heliyon.2023.e17477_bib10","article-title":"Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals","volume":"38b","author":"Demonbreun","year":"2021","journal-title":"EClinicalMedicine."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17477_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12985-021-01490-7","article-title":"Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein","volume":"18","author":"Tani","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.heliyon.2023.e17477_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108999","article-title":"For the Keio Donner Project. Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients","volume":"238","author":"Takeshita","year":"2022","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17477_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01533-20","article-title":"SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients","volume":"58","author":"Walker","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17477_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00560-21","article-title":"Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of antibodies to emerging variants","volume":"9","author":"Morinaga","year":"2021","journal-title":"Microbiol. Spectr."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17477_bib15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jiac.2022.02.024","article-title":"Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers","volume":"28","author":"Ikezaki","year":"2022","journal-title":"J. Infect. Chemother."},{"issue":"10316","key":"10.1016\/j.heliyon.2023.e17477_bib16","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.heliyon.2023.e17477_bib17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 vaccine booster against covid-19 in Israel","volume":"385","author":"Bar-On","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.heliyon.2023.e17477_bib18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMc2113468","article-title":"SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3","volume":"385","author":"Falsey","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023046856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023046856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:15:43Z","timestamp":1766171743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023046856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2405844023046856"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17477","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody level dynamics until after the third dose of COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e17477"}}